Perrigo Current Ratio 2012-2025 | PRGO
Perrigo current ratio from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Perrigo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $2.88B | $1.15B | 2.51 |
| 2025-06-30 | $2.62B | $1.13B | 2.32 |
| 2025-03-31 | $2.53B | $1.07B | 2.36 |
| 2024-12-31 | $2.48B | $1.04B | 2.38 |
| 2024-09-30 | $3.71B | $1.45B | 2.56 |
| 2024-06-30 | $2.96B | $1.49B | 1.99 |
| 2024-03-31 | $2.81B | $1.56B | 1.81 |
| 2023-12-31 | $2.83B | $1.59B | 1.79 |
| 2023-09-30 | $2.77B | $1.01B | 2.74 |
| 2023-06-30 | $2.77B | $1.06B | 2.62 |
| 2023-03-31 | $2.74B | $1.09B | 2.52 |
| 2022-12-31 | $2.72B | $1.11B | 2.44 |
| 2022-09-30 | $2.58B | $1.02B | 2.55 |
| 2022-06-30 | $2.65B | $1.02B | 2.61 |
| 2022-03-31 | $3.94B | $0.98B | 4.01 |
| 2021-12-31 | $3.86B | $1.59B | 2.43 |
| 2021-09-30 | $4.23B | $2.00B | 2.11 |
| 2021-06-30 | $4.42B | $1.99B | 2.23 |
| 2021-03-31 | $4.49B | $1.45B | 3.10 |
| 2020-12-31 | $3.13B | $1.38B | 2.27 |
| 2020-09-30 | $3.40B | $1.34B | 2.54 |
| 2020-06-30 | $3.80B | $1.86B | 2.05 |
| 2020-03-31 | $3.05B | $1.64B | 1.86 |
| 2019-12-31 | $2.73B | $1.34B | 2.04 |
| 2019-09-30 | $2.74B | $1.33B | 2.07 |
| 2019-06-30 | $3.44B | $1.79B | 1.92 |
| 2019-03-31 | $3.01B | $1.83B | 1.64 |
| 2018-12-31 | $2.90B | $1.54B | 1.89 |
| 2018-09-30 | $2.77B | $1.49B | 1.85 |
| 2018-06-30 | $2.78B | $1.54B | 1.81 |
| 2018-03-31 | $2.90B | $1.39B | 2.08 |
| 2017-12-31 | $2.82B | $1.44B | 1.96 |
| 2017-09-30 | $2.97B | $1.73B | 1.72 |
| 2017-06-30 | $2.82B | $1.63B | 1.73 |
| 2017-03-31 | $5.11B | $2.49B | 2.06 |
| 2016-12-31 | $2.81B | $1.84B | 1.53 |
| 2016-09-30 | $2.62B | $1.51B | 1.73 |
| 2016-06-30 | $3.03B | $2.06B | 1.47 |
| 2016-03-31 | $3.02B | $2.22B | 1.36 |
| 2015-12-31 | $2.79B | $2.55B | 1.09 |
| 2015-09-30 | $2.88B | $1.66B | 1.73 |
| 2015-06-30 | $3.18B | $1.69B | 1.88 |
| 2015-03-31 | $5.13B | $1.28B | 4.00 |
| 2014-12-31 | $5.36B | $1.33B | 4.05 |
| 2014-09-30 | $2.63B | $1.02B | 2.59 |
| 2014-06-30 | $2.55B | $1.08B | 2.37 |
| 2014-03-31 | $2.30B | $0.95B | 2.42 |
| 2013-12-31 | $2.29B | $0.96B | 2.38 |
| 2013-09-30 | $2.37B | $0.74B | 3.18 |
| 2013-06-30 | $2.24B | $0.75B | 2.99 |
| 2013-03-31 | $1.70B | $0.67B | 2.52 |
| 2012-12-31 | $1.77B | $0.64B | 2.79 |
| 2012-09-30 | $1.90B | $0.63B | 3.02 |
| 2012-06-30 | $1.80B | $0.65B | 2.75 |
| 2012-03-31 | $1.79B | $0.63B | 2.84 |
| 2011-12-31 | $1.73B | $0.67B | 2.60 |
| 2011-09-30 | $1.30B | $0.62B | 2.09 |
| 2011-06-30 | $1.38B | $0.61B | 2.27 |
| 2011-03-31 | $1.26B | $0.57B | 2.22 |
| 2010-12-31 | $1.16B | $0.59B | 1.98 |
| 2010-09-30 | $1.02B | $0.57B | 1.78 |
| 2010-06-30 | $1.40B | $0.92B | 1.52 |
| 2010-03-31 | $1.15B | $0.45B | 2.53 |
| 2009-12-31 | $1.16B | $0.49B | 2.39 |
| 2009-09-30 | $1.10B | $0.46B | 2.40 |
| 2009-06-30 | $1.15B | $0.50B | 2.30 |
| 2009-03-31 | $1.04B | $0.44B | 2.37 |
| 2008-12-31 | $1.05B | $0.46B | 2.30 |
| 2008-09-30 | $1.12B | $0.48B | 2.35 |
| 2008-06-30 | $1.16B | $0.49B | 2.37 |
| 2008-03-31 | $0.86B | $0.42B | 2.05 |
| 2007-12-31 | $0.80B | $0.37B | 2.18 |
| 2007-09-30 | $0.75B | $0.34B | 2.17 |
| 2007-06-30 | $0.72B | $0.38B | 1.89 |
| 2007-03-31 | $0.71B | $0.34B | 2.10 |
| 2006-12-31 | $0.72B | $0.35B | 2.04 |
| 2006-09-30 | $0.69B | $0.33B | 2.07 |
| 2006-06-30 | $0.66B | $0.37B | 1.77 |
| 2006-03-31 | $0.59B | $0.35B | 1.70 |
| 2005-12-31 | $0.60B | $0.34B | 1.74 |
| 2005-09-30 | $0.61B | $0.33B | 1.84 |
| 2005-06-30 | $0.61B | $0.34B | 1.79 |
| 2005-03-31 | $0.66B | $0.36B | 1.81 |
| 2004-12-31 | $0.50B | $0.17B | 2.87 |
| 2004-09-30 | $0.48B | $0.17B | 2.80 |
| 2004-06-30 | $0.47B | $0.19B | 2.52 |
| 2004-03-31 | $0.46B | $0.19B | 2.47 |
| 2003-12-31 | $0.42B | $0.17B | 2.40 |
| 2003-09-30 | $0.37B | $0.16B | 2.38 |
| 2003-06-30 | $0.38B | $0.17B | 2.28 |
| 2003-03-31 | $0.38B | $0.17B | 2.29 |
| 2002-12-31 | $0.36B | $0.16B | 2.24 |
| 2002-09-30 | $0.35B | $0.17B | 2.04 |
| 2002-06-30 | $0.34B | $0.16B | 2.21 |
| 2002-03-31 | $0.31B | $0.14B | 2.24 |
| 2001-12-31 | $0.31B | $0.14B | 2.17 |
| 2001-09-30 | $0.34B | $0.16B | 2.08 |
| 2001-06-30 | $0.31B | $0.17B | 1.82 |
| 2001-03-31 | $0.33B | $0.15B | 2.18 |
| 2000-12-31 | $0.31B | $0.14B | 2.21 |
| 2000-09-30 | $0.31B | $0.14B | 2.19 |
| 2000-06-30 | $0.27B | $0.11B | 2.36 |
| 2000-03-31 | $0.28B | $0.10B | 2.82 |
| 1999-12-31 | $0.35B | $0.12B | 2.87 |
| 1999-09-30 | $0.38B | $0.14B | 2.78 |
| 1999-06-30 | $0.38B | $0.13B | 2.87 |
| 1999-03-31 | $0.45B | $0.16B | 2.82 |
| 1998-12-31 | $0.48B | $0.18B | 2.64 |
| 1998-09-30 | $0.41B | $0.15B | 2.66 |
| 1998-06-30 | $0.37B | $0.14B | 2.63 |
| 1998-03-31 | $0.32B | $0.13B | 2.48 |
| 1997-12-31 | $0.32B | $0.13B | 2.50 |
| 1997-09-30 | $0.31B | $0.14B | 2.28 |
| 1997-06-30 | $0.28B | $0.11B | 2.51 |
| 1997-03-31 | $0.28B | $0.12B | 2.42 |
| 1996-12-31 | $0.28B | $0.12B | 2.35 |
| 1996-09-30 | $0.29B | $0.11B | 2.58 |
| 1996-06-30 | $0.26B | $0.09B | 2.80 |
| 1996-03-31 | $0.28B | $0.10B | 2.92 |
| 1995-12-31 | $0.30B | $0.10B | 2.92 |
| 1995-09-30 | $0.30B | $0.12B | 2.55 |
| 1995-06-30 | $0.26B | $0.09B | 2.86 |
| 1995-03-31 | $0.26B | $0.09B | 2.80 |
| 1994-12-31 | $0.25B | $0.08B | 3.12 |
| 1994-09-30 | $0.25B | $0.10B | 2.60 |
| 1994-06-30 | $0.23B | $0.09B | 2.64 |
| 1994-03-31 | $0.23B | $0.09B | 2.62 |
| 1993-12-31 | $0.22B | $0.08B | 2.86 |
| 1993-09-30 | $0.24B | $0.11B | 2.12 |
| 1993-06-30 | $0.21B | $0.09B | 2.42 |
| 1993-03-31 | $0.20B | $0.07B | 2.76 |
| 1992-12-31 | $0.20B | $0.08B | 2.42 |
| 1992-09-30 | $0.19B | $0.08B | 2.44 |
| 1992-06-30 | $0.16B | $0.07B | 2.26 |
| 1992-03-31 | $0.15B | $0.07B | 2.35 |
| 1991-09-30 | $0.15B | $0.06B | 2.50 |
| 1991-06-30 | $0.09B | $0.06B | 1.70 |
| 1990-06-30 | $0.09B | $0.05B | 1.84 |
| 1989-06-30 | $0.00B | 0.00 | |
| 1987-06-30 | $0.05B | $0.02B | 2.32 |
| 1986-06-30 | $0.05B | $0.02B | 2.27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.964B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.676B | 21.18 |
| EssilorLuxottica (ESLOY) | France | $140.849B | 0.00 |
| Stryker (SYK) | United States | $138.598B | 26.59 |
| Medtronic (MDT) | Ireland | $131.983B | 18.29 |
| Boston Scientific (BSX) | United States | $115.097B | 25.46 |
| Medline (MDLN) | United States | $60.694B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.604B | 0.00 |
| ResMed (RMD) | United States | $38.903B | 25.98 |
| GE HealthCare Technologies (GEHC) | United States | $37.513B | 17.97 |
| Agilent Technologies (A) | United States | $36.753B | 23.23 |
| Koninklijke Philips (PHG) | Netherlands | $27.809B | 18.16 |
| Terumo (TRUMY) | Japan | $18.896B | 21.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.585B | 10.97 |
| Insulet (PODD) | United States | $17.105B | 53.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.943B | 0.00 |
| Baxter (BAX) | United States | $11.191B | 9.03 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.080B | 29.05 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.301B | 13.10 |
| Envista Holdings (NVST) | United States | $4.063B | 20.59 |
| BillionToOne (BLLN) | United States | $3.897B | 0.00 |
| ICU Medical (ICUI) | United States | $3.694B | 23.45 |
| Prestige Consumer Healthcare (PBH) | United States | $3.152B | 14.63 |
| Haemonetics (HAE) | United States | $3.044B | 13.22 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.014B | 0.00 |
| Neogen (NEOG) | United States | $2.304B | 50.43 |
| Phibro Animal Health (PAHC) | United States | $2.027B | 17.86 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| QuidelOrtho (QDEL) | United States | $1.949B | 12.53 |
| AtriCure (ATRC) | United States | $1.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.466B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.466B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.421B | 20.57 |
| Green Thumb Industries (GTBIF) | United States | $1.417B | 62.09 |
| BioLife Solutions (BLFS) | United States | $1.060B | 314.57 |
| Capricor Therapeutics (CAPR) | United States | $1.053B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 10.59 |
| Tilray Brands (TLRY) | Canada | $0.821B | 0.00 |
| Valneva SE (VALN) | France | $0.803B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.790B | 0.00 |
| Omeros (OMER) | United States | $0.761B | 0.00 |
| CeriBell (CBLL) | United States | $0.717B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.66 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.411B | 0.00 |
| Brainsway (BWAY) | Israel | $0.410B | 69.77 |
| Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.326B | 26.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.286B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.201B | 18.06 |
| Organigram Global (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.200B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.196B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.191B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.188B | 55.17 |
| Sanara MedTech (SMTI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.175B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.69 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.49 |
| Sharps Technology (STSS) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.85 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| ZeroStack (ZSTK) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |